COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  M. Kirienko,et al.  FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  C. Roy,et al.  Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels , 2020, Radiology.

[4]  T. Liang,et al.  Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study , 2020, BMJ.

[5]  Jun Zhou,et al.  Chest CT findings of COVID-19 pneumonia by duration of symptoms , 2020, European Journal of Radiology.

[6]  S. Fanti,et al.  COVID-19 pandemic: guidance for nuclear medicine departments , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  L. Camporota,et al.  COVID-19 pneumonia: different respiratory treatments for different phenotypes? , 2020, Intensive Care Medicine.

[8]  Annarita Ianniello,et al.  18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging , 2020, Journal of Thoracic Oncology.

[9]  Yiyan Song,et al.  Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19 , 2020, Journal of medical virology.

[10]  S. Xiao,et al.  Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies , 2020, Modern Pathology.

[11]  Sijuan Zou,et al.  FDG PET/CT of COVID-19 , 2020, Radiology.

[12]  Chengcheng Yu,et al.  Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  P. Khong,et al.  COVID-19 pneumonia: what has CT taught us? , 2020, The Lancet Infectious Diseases.

[14]  Fang Liu,et al.  18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  Z. Fayad,et al.  Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection , 2020, Radiology.

[16]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[17]  Sang Hyun Hwang,et al.  Evaluation of Spleen Glucose Metabolism Using 18F-FDG PET/CT in Patients with Febrile Autoimmune Disease , 2017, The Journal of Nuclear Medicine.

[18]  Philip J. Sayre,et al.  Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge , 2015, EJNMMI Research.

[19]  M. Tucci,et al.  Assessment of lung inflammation with 18F-FDG PET during acute lung injury. , 2010, AJR. American journal of roentgenology.

[20]  M. Mintun,et al.  [18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation. , 2009, American journal of respiratory and critical care medicine.

[21]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[22]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[23]  Hisataka Kobayashi,et al.  Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  J. Vanoverschelde,et al.  Glucose for the heart. , 1999, Circulation.

[25]  B. Tribukait,et al.  Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. , 1991, Experimental cell research.

[26]  Runsheng Wang,et al.  A Retrospective Observational Study , 2020 .

[27]  G. Rossi,et al.  Pulmonary sarcoidosis. , 2018, The Lancet. Respiratory medicine.

[28]  R. Govindarajan,et al.  Pulmonary sarcoidosis. , 1985, The Journal of the Association of Physicians of India.